Stepahead Australia Ltd

StepAhead Australia :: Home

For the 2021/2022 project financial years we have continued our efforts in the following areas: Working in collaboration with international biotech and clinical research partners, Melbournebased investigators supported by our charity have been researching the benefits of infusing a naturally occurring protein called Decorin for treatment of traumatic spinal cord injury. As previously reported for the 2020/2021 project financial years, the disruptions due to lockdowns in Melbourne in response to the Covid19 pandemic in the 2021/2022 financial year again significantly impacted the ability of the Melbourne based Spinal Cord Injury Research (SCIR) team to conduct experimental studies supporting the clinical development and translation of Decorin to use in humans. In accordance with Monash University policies and directives, the research team were unable to conduct long term studies investigating the molecular and cell biology supporting locomotor recovery in preclinical studies of chronic spinal cord injury, with the last Melbourne lockdown ending on the 21st October 2021. The team therefore continued analysis of data sets collected from preclinical studies conducted prior to Covid19 lockdown restrictions. Importantly however, the SCIR team continued to build a new collaboration with a Sydneybased company called Isodynamics Reviver Corporation that has developed a novel rehabilitation technology for patients with neurological disorders. The new collaboration has focused on planning clinical trials to determine the optimum means of combining exercise rehab with Decorin infusion treatment to further enhance recovery of neurological function after traumatic spinal cord injury. The activities of our charity have therefore continued to focus on supporting clinically relevant scientific research that has a clear path to clinical trials for neurological disorders in humans.
15130364019
IČO
VIC 3844
Adresa
stepahead.org.au
Web
Popis

StepAhead Australia Ltd

StepAhead Australia Ltd is a nonprofit organization dedicated to funding the development of novel therapies for promoting repair of the injured and diseased nervous system. The organization's focus is particularly on therapies that enhance "neuroplasticity," the process of forming new neural circuits, which is crucial for treating chronic spinal cord injuries (cSCI) and other neurological disorders.

Mission and Objectives

StepAhead Australia's mission involves a multi-faceted approach to improve the quality of life for patients with chronic spinal cord injuries. This includes facilitating collaboration among scientists, clinicians, government entities, and businesses to develop effective treatments for spinal paralysis. By supporting innovative researchers and clinicians both in Australia and globally, the organization aims to advance breakthrough technologies for nervous system repair.

Approximately 15,000 Australians live with severe spinal cord injuries, with around 350 to 400 new cases reported annually. The economic impact on health care is substantial, with an estimated annual cost of $2 billion. Despite these costs, funding for spinal cord injury research is limited compared to other conditions like cancer.

Governance and Structure

StepAhead Australia is governed by a Board comprising its principal benefactors. The organization has also appointed a Scientific Advisory Board (SAB) consisting of internationally recognized scientists, biotechnologists, and clinicians. This advisory board provides expertise in the field to guide research initiatives.

Partnerships and Funding

StepAhead Australia benefits from partnerships with other organizations that share its mission. For example, the Lions Australia Spinal Cord Fellowship has been instrumental in raising awareness and funds to support StepAhead's research efforts, contributing over $2.3 million to date. This partnership highlights the collaborative approach taken by StepAhead to address the challenges of spinal cord injuries.

Impact

The work of StepAhead Australia not only focuses on improving the lives of those affected by spinal cord injuries but also has broader implications for treating other neurological disorders. By advancing neuroplasticity therapies, the organization seeks to enhance medical capabilities and offer hope for patients and families affected by debilitating neurological conditions.

References

  • [1]
  • [2]
  • [3]
  • [5]

[1] https://www.stepahead.org.au [2] https://www.acnc.gov.au/charity/charities/15a03e5e-38af-e811-a963-000d3ad24077 [3] https://www.stepahead.org.au/about-us/ [4] https://www.acnc.gov.au/charity/charities/15a03e5e-38af-e811-a963-000d3ad24077/documents/9f3c989d-d484-ee11-8179-002248122521 [5] https://lionsclubs.org.au/news/lions-spinal-cord-fellowship-raising-funds-for-step-ahead-australia/

Více

Poslední komentáře

Absolutely inspired by the work StepAhead Australia is doing! Supporting the development of new therapies for spinal cord injury is so vital. Let’s keep pushing for breakthroughs that can change lives! 💙🙌
detail
This is such important research! It’s heartbreaking to know the impact of chronic spinal cord injuries, but I believe in the power of neuroplasticity and the hope it brings. Together, we can make a difference! 🌟 #StepAheadAustralia
detail

Poslední diskuze

1. What innovative fundraising strategies can NGOs like StepAhead Australia implement to increase awareness and support for spinal cord injury research and therapy development?
Odpovědí: 3, Naposledy před 1 den detail
2. How can collaboration between StepAhead Australia and other organizations enhance the pursuit of breakthroughs in neuroplasticity and nervous system repair therapies?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
Stepahead Australia Ltd logo
Stepahead Australia Ltd
+ Sledovat
4.5
Reviews
VIC 3844
Místo
O společnosti

- E61, G20 -

StepAhead Australia Global Awareness At present there are no clinically approved interventions that can promote significant recovery of spinal function after SCI particularly for patients with long term chronic injuries. Breakthrough Research StepAhead Australia aggressively pursues the development of breakthrough nervous system repair technologies that can have a major impact on the quality of life for people suffering with chronic neurological disorders. Treating Sufferers Approximately 15000 patients in Australia live with the severe consequences of cSCI with approximately 350400 new cases each year. StepAhead Australias mission is to fund the development of novel therapies for promoting repair of the injured and diseased nervous system.

Související s dodávkou krve Vrozené vady, genetická onemocnění
23 Vacancy More Detail